APA-referens

Rivera, L., Pedersen, R. S., Peña, L., Olsen, K. J., Andreasen, L. V., Kromann, I., . . . Thierry-Carstensen, B. (2017). Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: A phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. Lancet Infect Dis.

Chicago-stil citat

Rivera, Luis, et al. "Immunogenicity and Safety of Three Aluminium Hydroxide Adjuvanted Vaccines With Reduced Doses of Inactivated Polio Vaccine (IPV-Al) Compared With Standard IPV in Young Infants in the Dominican Republic: A Phase 2, Non-inferiority, Observer-blinded, Randomised, and Controlled Dose Investigation Trial." Lancet Infect Dis 2017.

MLA-referens

Rivera, Luis, et al. "Immunogenicity and Safety of Three Aluminium Hydroxide Adjuvanted Vaccines With Reduced Doses of Inactivated Polio Vaccine (IPV-Al) Compared With Standard IPV in Young Infants in the Dominican Republic: A Phase 2, Non-inferiority, Observer-blinded, Randomised, and Controlled Dose Investigation Trial." Lancet Infect Dis 2017.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.